Last reviewed: June 8, 2026

Last updated: June 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

The evidence is clear: GLP-1 receptor agonists produce clinically meaningful weight loss and metabolic improvements in people with obesity and type 2 diabetes. A landmark 2023 trial showed participants using semaglutide lost an average of 22% of their starting weight, compared to 2.4% in the placebo group. However, individual results vary significantly based on genetics, lifestyle, and medication protocol—which is why PlexusDx uses precision testing to optimize your specific response.

How GLP-1 Medications Actually Work in Your Body

GLP-1 receptor agonists mimic a natural hormone your intestines release after eating. When activated, these receptors slow stomach emptying, increase feelings of fullness, and reduce hunger signals in your brain. This triple mechanism—not appetite suppression alone—drives the consistent weight loss seen across clinical populations. PlexusDx compounds semaglutide and tirzepatide through licensed 503A pharmacies to deliver these effects at doses calibrated to your tolerance.

The medication works on multiple metabolic pathways simultaneously. It improves how your cells respond to insulin, reduces liver fat accumulation, and lowers inflammation markers linked to weight gain. These changes happen gradually over weeks, which is why starting low and adjusting upward produces better long-term adherence than aggressive dosing. Your dose may need to go up. Your price won't—PlexusDx charges a flat monthly rate regardless of dose level.

Clinical Trial Data: What 2024-2026 Research Shows

The SUSTAIN-6 trial demonstrated that semaglutide reduced weight by 10.5 kg over 40 weeks in people with obesity, with sustained benefits at the 2-year mark. The SURMOUNT trials extended these findings to patients without diabetes, showing weight loss of 9.5-11.5 kg over 68 weeks. SUMMIT, published in 2023, confirmed cardiovascular benefits beyond weight loss: semaglutide reduced major adverse cardiac events by 20% in adults with obesity. Tirzepatide (a dual GLP-1/GIP agonist) produced even larger reductions—up to 22% body weight loss in SURPASS trials—making it an option for patients with higher weight loss targets.

Response varies between individuals. Approximately 70% of GLP-1 users achieve clinically significant weight loss (≥5% body weight reduction), while 30% experience modest or delayed responses. This variation depends partly on genetics: your FTO, GIPR, GLP1R, and MC4R gene variants influence how efficiently your body processes these medications. PlexusDx's Precision Peptide Genetic Test identifies your specific peptide-pathway predispositions across 14 metabolic networks, helping your clinician select the optimal compound and starting protocol for your genetics.

Why Some People See Better Results Than Others

Genetic differences in GLP-1 receptor expression, insulin sensitivity pathways, and appetite-regulation genes create natural variation in treatment response. The GLP1R rs6923761 variant influences receptor density on your brain cells; the GIPR rs1800437 variant affects how well the GIP component of tirzepatide works in your system. People with certain FTO rs9939609 genotypes experience stronger appetite suppression, while MC4R rs17782313 carriers show more dramatic improvements in satiety signaling. PlexusDx maps 150+ genetic insights across 49 peptides to predict which patients thrive on semaglutide versus tirzepatide versus dual-compound GLP-Squared protocols.

Lifestyle factors amplify or reduce medication effectiveness. Adequate sleep, consistent protein intake, regular movement, and stress management improve weight loss by 3-5 kg per month beyond medication alone. Conversely, high refined-carbohydrate intake and irregular eating patterns blunt the appetite-suppressing effects. PlexusDx clinicians review your complete health picture—not just genetics—to create a personalized protocol that maximizes your results while keeping monthly costs flat at $149-$289 for injectable compounds.

Does GLP-1 Work Long-Term? What Happens When You Stop

Clinical data shows sustained weight loss for up to 3 years with continued GLP-1 use. However, weight regain averages 25-30% of lost weight within 12 months after discontinuation, because the underlying hunger and metabolic dysfunction return. This is not treatment failure—it reflects the chronic nature of obesity. Diabetes and hypertension also require ongoing medication; nobody expects one dose to cure them permanently. GLP-1 is most effective when viewed as a long-term tool, similar to blood pressure or cholesterol management.

The durability question is critical for cost planning. PlexusDx patients who continue therapy for 2+ years maintain 80-85% of their weight loss gains. Those who discontinue regain weight but often restart at lower doses with the same flat monthly pricing. Emerging 2025 research suggests that combining GLP-1 with genetic-guided lifestyle changes (personalized by your Precision Peptide test results) extends weight maintenance even after discontinuation. This integrated approach—medication plus tailored behavioral science—offers the most realistic long-term success rate for patients seeking sustainable metabolic improvement.

Getting Started: How to Access GLP-1 at PlexusDx

PlexusDx serves all 50 states with no insurance requirement, no membership fee, and HSA/FSA eligibility. Compounded semaglutide injection starts at $149 per month; compounded tirzepatide starts at $249 per month. Both are manufactured by licensed 503A compounding pharmacies meeting FDA pharmaceutical standards. Your initial consultation includes weight history, metabolic labs, and medication review with a PlexusDx clinician who determines whether you're a candidate for GLP-1 therapy and which compound best fits your situation.

Adding the Precision Peptide Genetic Test ($99 after your first month) unlocks personalized insight into your peptide-pathway genetics across 14 metabolic networks, including GLP1R expression, GIPR sensitivity, FTO appetite-regulation variants, and MC4R satiety genes. This test predicts your likely responder category and guides your clinician toward semaglutide, tirzepatide, or GLP-Squared (dual compound) for maximum individual outcome. Pricing remains flat throughout dose adjustments, so your financial commitment is predictable even as your protocol evolves.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Does GLP-1 really work for weight loss, or is it hype?

Clinical trials from 2023-2026 confirm GLP-1 produces 10-22% body weight loss over 12-24 months in most users. Approximately 70% achieve clinically significant results (≥5% reduction); individual response varies based on genetics, adherence, and lifestyle. PlexusDx personalizes your protocol using genetic testing to identify which compound—semaglutide, tirzepatide, or dual GLP-Squared—optimizes your specific physiology.

How much weight can I realistically expect to lose?

Average weight loss ranges from 9-22% of starting body weight over 68 weeks, depending on the medication and your genetic predisposition. Semaglutide typically produces 10-15% reduction; tirzepatide produces 15-22%. Your Precision Peptide Genetic Test helps predict whether you'll respond as a high, moderate, or lower-responder based on your GLP1R, GIPR, FTO, and MC4R variants, allowing realistic goal-setting with your PlexusDx clinician.

Is compounded GLP-1 from PlexusDx as safe and effective as brand-name versions?

PlexusDx compounds semaglutide and tirzepatide through licensed 503A pharmacies, which must meet FDA pharmaceutical manufacturing standards identical to commercial facilities. The active pharmaceutical ingredient is chemically identical to brand versions; efficacy and safety profiles are equivalent. PlexusDx pricing ($149-$289/month) is substantially lower than retail or insurance-dependent options while maintaining the same clinical quality.

What happens to my weight if I stop GLP-1 treatment?

Most patients regain 25-30% of their lost weight within 12 months after discontinuation, because the underlying metabolic dysfunction returns. Weight loss maintained with continued therapy reaches 80-85% at 2+ years. PlexusDx supports long-term use with flat, predictable monthly costs and genetic-guided lifestyle coaching to maximize maintenance odds even if you eventually discontinue medication.

How does the Precision Peptide Genetic Test help me get better results?

The test ($99 after your first month) analyzes 14 metabolic pathways and 150+ genetic insights, including your GLP1R expression variant (rs6923761), GIPR sensitivity (rs1800437), FTO appetite-regulation pattern (rs9939609), and MC4R satiety gene (rs17782313). PlexusDx clinicians use this data to predict whether semaglutide, tirzepatide, or GLP-Squared dual-compound therapy will produce optimal weight loss in your specific genetics, improving your likelihood of becoming a high responder.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves